Investigación / Grupos de investigación

Grupo  1

Bases Neurobiológicas y Psicológicas de los Trastornos Mentales. Trastornos del Neurodesarrollo

Publicaciones (889)

  • Diaz-Caneja, CM; Alloza, C; Gordaliza, PM; Fernandez-Pena, A; de Hoyos, L; Santonja, J; Buimer, EEL; van Haren, NEM; Cahn, W; Arango, C; Kahn, RS; Pol, HEH; Schnack, HG; Janssen, J.

    Sex Differences in Lifespan Trajectories and Variability of Human Sulcal and Gyral Morphology

    CEREBRAL CORTEX. 2021; 31(11): 5107-5120 Nº de citas: 3 [doi:10.1093/cercor/bhab145]

  • Amoretti, S; Rabelo-da-Ponte, FD; Rosa, AR; Mezquida, G; Sanchez-Torres, AM; Fraguas, D; Cabrera, B; Lobo, A; Gonzalez-Pinto, A; Pina-Camacho, L; Corripio, I; Vieta, E; Torrent, C; de la Serna, E; Berge, D; Bioque, M; Garriga, M; Serra, M; Cuesta, MJ; Bernardo, M; PEPs Grp.

    Cognitive clusters in first-episode psychosis

    SCHIZOPHRENIA RESEARCH. 2021; 237: 31-39 Nº de citas: 22 [doi:10.1016/j.schres.2021.08.021]

  • Pallanti, S; Marras, A; Dickson, SL; Adan, RA; Vieta, E; Osso, BD; Arango, C; Fusar-Poli, P; Soriano-Mas, C; Carmi, L; Lindenberg, AM; Zohar, J.

    Manifesto for an ECNP Neuromodulation Thematic Working Group (TWG): Non-invasive brain stimulation as a new Super-subspecialty

    EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021; 52: 72-83 Nº de citas: 7 [doi:10.1016/j.euroneuro.2021.07.002]

  • de Pablo, GS; Solmi, M; Vaquerizo-Serrano, J; Radua, J; Passina, A; Mosillo, P; Correll, CU; Borgwardt, S; Galderisi, S; Bechdolf, A; Pfennig, A; Bauer, M; Kessing, LV; van Amelsvoort, T; Nieman, DH; Domschke, K; Krebs, MO; Sand, M; Vieta, E; McGuire, P; Arango, C; Il Shin, J; Fusar-Poli, P.

    Primary prevention of depression: An umbrella review of controlled interventions

    Journal of Affective Disorders. 2021; 294: 957-970 Nº de citas: 32 [doi:10.1016/j.jad.2021.07.101]

  • Marin-Navarrete, R; Torrens, M; Toledo-Fernandez, A; Mestre-Pinto, JI; Sanchez-Dominguez, R; Perez-Lopez, A; Saracco-Alvarez, R; Madrigal-De Leon, EA; Szerman, N.

    Developing an App to Screen for Dual Disorders: A Tool for Improving Treatment Services in Mexico

    Frontiers in Psychiatry. 2021; 12: 697598-697598 [doi:10.3389/fpsyt.2021.697598]

  • Gasso, P; Rodriguez, N; Martinez-Pinteno, A; Mezquida, G; Ribeiro, M; Gonzalez-Penas, J; Zorrilla, I; Martinez-Sadurni, L; Rodriguez-Jimenez, R; Corripio, I; Sarro, S; Ibanez, A; Usall, J; Lobo, A; Moren, C; Cuesta, MJ; Parellada, M; Gonzalez-Pinto, A; Berrocoso, E; Bernardo, M; Mas, S; 2EPs Grp.

    A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood

    Translational Psychiatry. 2021; 11(1): 539-539 Nº de citas: 6 [doi:10.1038/s41398-021-01645-8]

  • Canal-Rivero, M; Ayesa-Arriola, R; Setien-Suero, E; Crespo-Facorro, B; Arango, C; Dutta, R; Lopez-Morinigo, JD.

    Understanding the Influence of Personality Traits on Risk of Suicidal Behaviour in Schizophrenia Spectrum Disorders: A Systematic Review

    Journal of Clinical Medicine. 2021; 10(19): Nº de citas: 2 [doi:10.3390/jcm10194604]

  • Arango, C; Dragioti, E; Solmi, M; Cortese, S; Domschke, K; Murray, RM; Jones, PB; Uher, R; Carvalho, AF; Reichenberg, A; Shin, JI; Andreassen, OA; Correll, CU; Fusar-Poli, P.

    Risk and protective factors for mental disorders beyond genetics: an evidence-based atlas

    World Psychiatry. 2021; 20(3): 417-436 Nº de citas: 187 [doi:10.1002/wps.20894]

  • Ferraro, L; La Cascia, C; La Barbera, D; Sanchez-Gutierrez, T; Tripoli, G; Seminerio, F; Sartorio, C; Marrazzo, G; Sideli, L; Arango, C; Arrojo, M; Bernardo, M; Bobes, J; Del-Ben, CM; Gayer-Anderson, C; Jongsma, HE; Kirkbride, JB; Lasalvia, A; Tosato, S; Llorca, PM; Menezes, PR; Rutten, BP; Santos, JL; Sanjuan, J; Selten, JP; Szoke, A; Tarricone, I; Muratori, R; Tortelli, A; Velthorst, E; Rodriguez, V; Quattrone, A; Jones, PB; Van Os, J; Vassos, E; Morgan, C; de Haan, L; Reininghaus, U; Cardno, AG; Di Forti, M; Murray, RM; Quattrone, D.

    The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study

    SCHIZOPHRENIA RESEARCH. 2021; 236: 69-79 Nº de citas: 8 [doi:10.1016/j.schres.2021.08.008]

  • Gonzalez-Blanco, L; Garcia-Portilla, MP; Gutierrez, M; Mezquida, G; Cuesta, MJ; Urbiola, E; Amoretti, S; Barcones, F; Gonzalez-Pinto, A; Pina-Camacho, L; Corripio, I; Vieta, E; Baeza, I; Toll, A; Saiz, PA; Bobes, J; Bernardo, M; PEPs Grp.

    Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis

    SCHIZOPHRENIA RESEARCH. 2021; 236: 19-28 Nº de citas: 7 [doi:10.1016/j.schres.2021.07.017]

  • Rapado-Castro, M; Villar-Arenzana, M; Janssen, J; Fraguas, D; Bombin, I; Castro-Fornieles, J; Mayoral, M; Gonzalez-Pinto, A; de la Serna, E; Parellada, M; Moreno, D; Paya, B; Graell, M; Baeza, I; Pantelis, C; Arango, C.

    Fronto-Parietal Gray Matter Volume Loss Is Associated with Decreased Working Memory Performance in Adolescents with a First Episode of Psychosis

    Journal of Clinical Medicine. 2021; 10(17): Nº de citas: 4 [doi:10.3390/jcm10173929]

  • Ballesteros, A; Torres, AMS; Lopez-Ilundain, J; Mezquida, G; Lobo, A; Gonzalez-Pinto, A; Pina-Camacho, L; Corripio, I; Vieta, E; de la Serna, E; Mane, A; Bioque, M; Moreno-Izco, L; Espliego, A; Lorente-Omenaca, R; Amoretti, S; Bernardo, M; Cuesta, MJ; PEPs Grp.

    The longitudinal effect of antipsychotic burden on psychosocial functioning in first-episode psychosis patients: the role of verbal memory

    PSYCHOLOGICAL MEDICINE. 2021; 51(12): 2044-2053 Nº de citas: 6 [doi:10.1017/S003329172000080X]

  • Sami, M; Quattrone, D; Ferraro, L; Tripoli, G; La Cascia, E; Gayer-Anderson, C; Selten, JP; Arango, C; Bernardo, M; Tarricone, I; Tortelli, A; Gatto, G; del Peschio, S; Del-Ben, CM; Rutten, BP; Jones, PB; van Os, J; de Haan, L; Morgan, C; Lewis, C; Bhattacharyya, S; Freeman, TP; Lynskey, M; Murray, RM; Di Forti, M.

    Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls

    PSYCHOLOGICAL MEDICINE. 2021; 51(12): 2074-2082 Nº de citas: 8 [doi:10.1017/S0033291720000847]

  • Valencia, F; Penelo, E; de la Osa, N; Navarro, JB; Ezpeleta, L.

    Prospective association of parental and child internalizing symptoms: Mediation of parenting practices and irritability

    BRITISH JOURNAL OF DEVELOPMENTAL PSYCHOLOGY. 2021; 39(3): 363-379 Nº de citas: 3 [doi:10.1111/bjdp.12367]

  • Persico, AM; Ricciardello, A; Lamberti, M; Turriziani, L; Cucinotta, F; Brogna, C; Vitiello, B; Arango, C.

    The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present

    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2021; 110: 110326-110326 Nº de citas: 71 [doi:10.1016/j.pnpbp.2021.110326]

  • Parellada, M; Caceres, ASJ; Palmer, M; Delorme, R; Jones, EJH; Parr, JR; Anagnostou, E; Murphy, DGM; Loth, E; Wang, PP; Charman, T; Strydom, A; Arango, C; AIMS-2-TRIALS-CT1 Grp.

    A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1

    Frontiers in Psychiatry. 2021; 12: 701729-701729 Nº de citas: 10 [doi:10.3389/fpsyt.2021.701729]

  • Panchal, U; de Pablo, GS; Franco, M; Moreno, C; Parellada, M; Arango, C; Fusar-Poli, P.

    The impact of COVID-19 lockdown on child and adolescent mental health: systematic review

    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2021; 32(7): 1-27 Nº de citas: 644 [doi:10.1007/s00787-021-01856-w]

  • Martinez-Pinteno, A; Gasso, P; Prohens, L; Segura, AG; Parellada, M; Saiz-Ruiz, J; Cuesta, MJ; Bernardo, M; Lafuente, A; Mas, S; Rodriguez, N.

    Identification of EP300 as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data

    Frontiers in Pharmacology. 2021; 12: 729474-729474 Nº de citas: 2 [doi:10.3389/fphar.2021.729474]